Company Filing History:

6 out of 4,945

Hoffmann-la Roche Inc.

patents

5 out of 1,164

Boehringer Mannheim Gmbh

patents

3 out of 480

Roche Diagnostics Gmbh

patents

4. 1 out of 1

Prof. Dr. Wolf-georg Forssmann

patent

5. 2 out of 832,843

Other

patents

Years Active: 1983-2011

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7939532 - Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents (2011-05-10),

2. 7879884 - Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents (2011-02-01),

3. 7625896 - Pyridylsulfonamide derivatives (2009-12-01),

4. 7429605 - Phenylpyridine derivatives (2008-09-30),

5. 7405231 - Oxidized thioether derivatives (2008-07-29),

6. 7005526 - Thioether derivatives (2006-02-28),

7. 6911553 - Osteoblast-specific mitogens and drugs containing such compounds (2005-06-28),

8. 6809175 - Cadherin derived growth factor and its use (2004-10-26),

9. 6444832 - Amino alcohol derivatives, method of producing said derivatives and medicaments containing them (2002-09-03),

10. 6429288 - Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds (2002-08-06),

11. 6197759 - Osteoblast-specific mitogens and drugs containing such compounds (2001-03-06),

12. 5888967 - Use of plasminogen activators to stimulate local bone growth (1999-03-30),

13. 5486530 - Use of torasemide for the treatment of brain oedemas (1996-01-23),

14. 4925845 - 2 heteroaryl 3,3 dialkyl-5-(3 oxo-2,3,4,5 tetrahydro-6 (1990-05-15),

15. 4882342 - 5-alkylbenzimidazoles, method of use and pharmaceutical compositions (1989-11-21),

Title: Lothar Kling: Innovator in Pharmaceutical Chemistry

Introduction

Lothar Kling is a distinguished inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 17 patents. His work primarily focuses on the development of novel compounds that have potential applications in the treatment and prevention of serious illnesses, including cancer.

Latest Patents

Among his latest patents are the "Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents." This invention encompasses compounds that are designed to be effective in controlling or preventing illnesses such as cancer. Another notable patent is the "Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents," which similarly aims to provide innovative solutions in the pharmaceutical industry.

Career Highlights

Lothar Kling has had a remarkable career, working with prominent companies such as Hoffmann-La Roche Inc. and Boehringer Mannheim GmbH. His expertise in pharmaceutical development has led to advancements that benefit both the medical community and patients worldwide.

Collaborations

Throughout his career, Lothar has collaborated with notable colleagues, including Wolfgang Von Der Saal and Angelika Esswein. These partnerships have fostered an environment of innovation and creativity, contributing to the success of his projects.

Conclusion

Lothar Kling's contributions to pharmaceutical chemistry through his numerous patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments, particularly in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com